Enhancing chemosensitivity to gemcitabine via RNA interference targeting the catalytic subunits of protein kinase CK2 in human pancreatic cancer cells
about
Protein kinase CK2 and human malignant tumorsDNA microarray reveals ZNF195 and SBF1 are potential biomarkers for gemcitabine sensitivity in head and neck squamous cell carcinoma cell linesCK2 in Cancer: Cellular and Biochemical Mechanisms and Potential Therapeutic Target.DKK3 blocked translocation of β-catenin/EMT induced by hypoxia and improved gemcitabine therapeutic effect in pancreatic cancer Bxpc-3 cell.BML-275, an AMPK inhibitor, induces DNA damage, G2/M arrest and apoptosis in human pancreatic cancer cellsTriptolide induces the expression of miR-142-3p: a negative regulator of heat shock protein 70 and pancreatic cancer cell proliferationNuclear localization of the CK2α-subunit correlates with poor prognosis in clear cell renal cell carcinoma.Emerging cell-cycle inhibitors for pancreatic cancer therapy.Protein kinase CK2 in breast cancer: the CK2β regulatory subunit takes center stage in epithelial plasticity.Stem Cell-Like Properties of CK2β-down Regulated Mammary Cells.Protein Kinase CK2α Maintains Extracellular Signal-regulated Kinase (ERK) Activity in a CK2α Kinase-independent Manner to Promote Resistance to Inhibitors of RAF and MEK but Not ERK in BRAF Mutant MelanomaThe kinase inhibitor D11 induces caspase-mediated cell death in cancer cells resistant to chemotherapeutic treatment.Molecular predictors of gemcitabine response in pancreatic cancer.Downregulation of protein kinase CK2 induces autophagic cell death through modulation of the mTOR and MAPK signaling pathways in human glioblastoma cells.2-Triazenoazaindoles: α novel class of triazenes inducing transcriptional down-regulation of EGFR and HER-2 in human pancreatic cancer cells.Lack of the catalytic subunit of DNA-dependent protein kinase (DNA-PKcs) is accompanied by increased CK2α' levels.Cytotoxic effects exerted by pentachlorophenol by targeting nodal pro-survival signaling pathways in human pancreatic cancer cells
P2860
Q27026335-D9A82E8B-0DAC-495F-A383-9F8475FB7105Q33582958-B19B58B0-1021-4366-B456-C935538B6197Q36263671-86DF3CE7-61C6-45A3-9DF7-14161DCCD921Q36394714-A179A9CD-D8E3-41E8-B292-3800775F4054Q36642909-4052A3D4-38B7-40C7-A438-60D1A7EBC98AQ37001384-22E7290E-1DA4-4738-9260-6F1F8CD6BED8Q37702141-D77E6D7B-2D98-4C8D-9F03-48B311A399B3Q38057759-8DA858CA-0B28-4CA2-AD27-B1324CD8E55EQ38492153-FD7CAE41-309D-42B8-956C-D691812B0FD2Q38600155-DBC7856E-4B10-4646-A0E7-160EABBAD4A5Q38768362-841FC19B-55AF-40C4-BC56-8B927F15A567Q38826790-DB5A3F73-B1C8-470D-B184-8AEB558FDEB0Q39250668-FF49A39C-4DE7-4DFD-9232-1F1E4DA1288FQ39272415-B49A49C2-7469-4486-B2F8-DAD1A6F0A84CQ39434302-E20461AD-DA58-42BC-AA63-E4D2EE239B12Q39507697-DD7E313B-631F-478A-8F63-315AF59F6590Q41680911-CB60F2D8-9D2B-4038-96C2-0B6CA7F4043B
P2860
Enhancing chemosensitivity to gemcitabine via RNA interference targeting the catalytic subunits of protein kinase CK2 in human pancreatic cancer cells
description
2010 nî lūn-bûn
@nan
2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Enhancing chemosensitivity to ...... human pancreatic cancer cells
@ast
Enhancing chemosensitivity to ...... human pancreatic cancer cells
@en
type
label
Enhancing chemosensitivity to ...... human pancreatic cancer cells
@ast
Enhancing chemosensitivity to ...... human pancreatic cancer cells
@en
prefLabel
Enhancing chemosensitivity to ...... human pancreatic cancer cells
@ast
Enhancing chemosensitivity to ...... human pancreatic cancer cells
@en
P2860
P356
P1433
P1476
Enhancing chemosensitivity to ...... human pancreatic cancer cells
@en
P2093
Jan N Kreutzer
P2860
P2888
P356
10.1186/1471-2407-10-440
P407
P577
2010-08-19T00:00:00Z
P5875
P6179
1024532391